Amalgamated Bank’s KalVista Pharmaceuticals KALV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15K | Hold |
1,343
| – | – | ﹤0.01% | 2239 |
|
|
2025
Q1 | $15K | Buy |
1,343
+278
| +26% | +$3.11K | ﹤0.01% | 2181 |
|
|
2024
Q4 | $9K | Hold |
1,065
| – | – | ﹤0.01% | 2482 |
|
|
2024
Q3 | $12K | Hold |
1,065
| – | – | ﹤0.01% | 2361 |
|
|
2024
Q2 | $13K | Hold |
1,065
| – | – | ﹤0.01% | 2307 |
|
|
2024
Q1 | $13K | Sell |
1,065
-1,028
| -49% | -$12.5K | ﹤0.01% | 2322 |
|
|
2023
Q4 | $26K | Sell |
2,093
-231
| -10% | -$2.87K | ﹤0.01% | 2532 |
|
|
2023
Q3 | $22K | Hold |
2,324
| – | – | ﹤0.01% | 2614 |
|
|
2023
Q2 | $21K | Sell |
2,324
-112
| -5% | -$1.01K | ﹤0.01% | 2714 |
|
|
2023
Q1 | $19K | Sell |
2,436
-568
| -19% | -$4.43K | ﹤0.01% | 2668 |
|
|
2022
Q4 | $20K | Hold |
3,004
| – | – | ﹤0.01% | 2750 |
|
|
2022
Q3 | $44K | Hold |
3,004
| – | – | ﹤0.01% | 2519 |
|
|
2022
Q2 | $30K | Sell |
3,004
-648
| -18% | -$6.47K | ﹤0.01% | 2718 |
|
|
2022
Q1 | $54K | Buy |
+3,652
| New | +$54K | ﹤0.01% | 2444 |
|